Skip to main content

Lee Frank D.

In the past year, 1 open-market sale filing worth $132.8K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$132.8K
1 filing
Net
−$132.8K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Lee Frank D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BHC Bausch Health Companies Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 22, 2025 (view filing)Aug 211 dayLee Frank D.DirectorSSaleCommon Shares, No Par Value−15.9K$7.66−$121.9K−17.7%73.8K after
May 20, 2026 (view filing)May 191 dayLee Frank D.DirectorSSaleCommon Shares, No Par Value−24.5K$5.43−$132.8K−33.1%49.3K after10b5-1

PCRX Pacira BioSciences, Inc.

Chief Executive Officer1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 13, 2024 (view filing)Aug 121 dayLee Frank D.Chief Executive OfficerPPurchase+8.26K$12.10+$100.0K+8.3%107.8K after

FMTX Forma Therapeutics Holdings, Inc.

President and CEO1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 25, 2022 (view filing)Feb 232 daysLee Frank D.President and CEOSSale−18.0K$9.78−$175.9K−18.4%79.8K after